QUEST DIAGNOSTICS INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 144.6 USD | +0.33% |
|
+4.08% | +4.87% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
23/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
144.6
USD
Average target price
150.4
USD
Spread / Average Target
+4.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.87% | 16.06B | |
| +17.11% | 83.02B | |
| -25.70% | 73.65B | |
| 0.00% | 26.5B | |
| +2.67% | 17.72B | |
| -8.71% | 17.49B | |
| +79.85% | 13.83B | |
| +73.90% | 12.84B | |
| -26.14% | 12.73B | |
| +29.77% | 11.92B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Leerink Adjusts Price Target on Quest Diagnostics to $151 From $141, Maintains Market Perform Rating
